Alvantis

Shenzhen Alvantis Pharma Co., Ltd. specializes in the research and development of GLP-1R agonist Peptide (Tirzepatide and Semaglutide) and other  therapeutic peptide APIs and Formulation.Alvtantis has more than 10 years of experience in peptide synthesis, structural modification, quality research and formulation optimization. At the same time, with the United States ANDA and Chinese drug application experience, Alvantis has an extraordinary advantage in  peptide research, DS development and DP formulations. In addition, we can provide other types of specialty chemicals or pharmaceutical products (including aseptic  APIs in Vial on request) , as well as ranging from gram laboratory sizes sample to kilogram GMP level peptide.